SIRT1 and gastric adenocarcinoma: As shown in Figure 7A,B, SIRT1 expression was significantly correlated with poor overall survival (OS) in stomach adenocarcinoma patients and poor recurrence-free survival (RFS) in kidney renal papillary cell carcinoma patients (p < 0.05).